As glioblastoma continues to challenge the medical community, the Foundation unveils a new genomic testing lab, an advancing drug pipeline, and a sharper focus on accelerating personalized treatment for patients ahead of Glioblastoma Awaren…
What we can learn from tumor biology—and why no two glioblastomas are exactly alike Glioblastoma continues to be among the most difficult brain cancers to manage. As the most common and aggressive form, it has historically been approached a…
In June 2025, Cell Reports Medicine published the results of an international clinical trial investigating Lisavanbulin, a new experimental pill for people with glioblastoma and other high-grade gliomas. Glioblastoma is an aggressive brain
While recent innovations like targeted therapies have revolutionized care for many other cancer types, the standard of care for glioblastoma has changed little in the past two decades. Currently, treatment consists of surgery to remove as m…
TransformingGlioblastomaTherapy The mission of the Glioblastoma Foundation is to transform the standard of care for glioblastoma. We support the development of new drugs and other effective therapies for glioblastoma. Because each glioblast…
Congratulations to Dr. Vinay Puduvalli on his newly funded NIH grant entitled “Characterization of Onalespib, A novel long acting Hsp90 inhibitor, as a chemo and radiosensitizer in Adults with Newly Diagnosed Glioblastoma.” We are proud to
Glioblastoma Foundation is pleased to announce the funding of a high impact, FDA-approved technology known as MRI-guided focused ultrasound, specifically for the treatment of glioblastoma, at Weill-Cornell Medical Center. The research is in…
TransformingGlioblastomaTherapy The mission of the Glioblastoma Foundation is to transform the standard of care for glioblastoma. We support the development of new drugs and other effective therapies for glioblastoma. Because each glioblast…
TransformingGlioblastomaTherapy Gold Supporters donate money to allow the Foundation to accomplish a major research objective at the preclinical level. Glioblastoma FoundationP.O.Box 62066Durham, NC 27715Email: info@glioblastomafoundation.o…
TransformingGlioblastomaTherapy “Time matters. Days matter. Minutes matter.” — Vice President Joe Biden Glioblastoma (also known as Glioblastoma multiforme or GBM) is the most aggressive type of tumor that arises in the brain. It is one of
TransformingGlioblastomaTherapy Glioblastoma FoundationP.O.Box 62066Durham, NC 27715Email: info@glioblastomafoundation.orgPhone: 919-402-1775 The mission of the Glioblastoma Foundation is to transform the standard of care for glioblastoma.
TransformingGlioblastomaTherapy Join the Glioblastoma Foundation in celebrating the life and legacy of Let’s Active drummer Sara Romweber! The Glioblastoma Foundation is proud to announce the First Annual Rock Against Glioblastoma Music Fes…